Figure 3From: Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic isletsDistribution of sites that exhibit differential DNA methylation between female and male pancreatic islets. (A-D) The absolute difference in DNA methylation of individual sites with a significant difference in methylation between male and female pancreatic islets (q <0.05, based on an FDR analysis) divided into 5% bars. The absolute differences in DNA methylation of sites on the autosomal chromosomes with significantly higher methylation levels in females compared with males (n = 1,120) (A) or significantly higher methylation levels in males compared with females (n = 403) (B). The absolute differences in DNA methylation of sites on the X chromosome with significantly higher methylation levels in females compared with males (n = 6,136) (C) or significantly higher methylation levels in males compared with females (n = 4,088) (D) based on FDR with q <0.05. (E,F) The distribution of significant sites (q <0.05, delta β-value >5%) versus all analyzed sites on the autosomal chromosomes in relation to genomic regions (E) and CpG island regions (F). (G,H) The distribution of significant sites (q <0.05, delta β-value >5%) versus all analyzed sites on the X chromosome in relation to genomic regions (G) and CpG island regions (H). Asterisks indicate significant (corrected P-value <0.05) based on a chi2 test of observed and expected significant and non-significant number of sites in each region. P-values in (E-H) have been corrected for multiple testing using Bonferroni correction.Back to article page